Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Cachexia is a multifactorial metabolic syndrome with high morbidity and mortality in patients with advanced cancer. The diagnosis of cancer cachexia depends on objective measures of clinical symptoms and a history of weight loss, which lag behind disease progression and have limited utility for the early diagnosis of cancer cachexia. In this study, we performed a nuclear magnetic resonance‐based metabolomics analysis to reveal the metabolic profile of cancer cachexia and establish a diagnostic model. Methods: Eighty‐four cancer cachexia patients, 33 pre‐cachectic patients, 105 weight‐stable cancer patients, and 74 healthy controls were included in the training and validation sets. Comparative analysis was used to elucidate the distinct metabolites of cancer cachexia, while metabolic pathway analysis was employed to elucidate reprogramming pathways. Random forest, logistic regression, and receiver operating characteristic analyses were used to select and validate the biomarker metabolites and establish a diagnostic model. Results: Forty‐six cancer cachexia patients, 22 pre‐cachectic patients, 68 weight‐stable cancer patients, and 48 healthy controls were included in the training set, and 38 cancer cachexia patients, 11 pre‐cachectic patients, 37 weight‐stable cancer patients, and 26 healthy controls were included in the validation set. All four groups were age‐matched and sex‐matched in the training set. Metabolomics analysis showed a clear separation of the four groups. Overall, 45 metabolites and 18 metabolic pathways were associated with cancer cachexia. Using random forest analysis, 15 of these metabolites were identified as highly discriminating between disease states. Logistic regression and receiver operating characteristic analyses were used to create a distinct diagnostic model with an area under the curve of 0.991 based on three metabolites. The diagnostic equation was Logit(P) = −400.53 – 481.88 × log(Carnosine) −239.02 × log(Leucine) + 383.92 × log(Phenyl acetate), and the result showed 94.64% accuracy in the validation set. Conclusions: This metabolomics study revealed a distinct metabolic profile of cancer cachexia and established and validated a diagnostic model. This research provided a feasible diagnostic tool for identifying at‐risk populations through the detection of serum metabolites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767 · cited 2×
“As cachexia can develop progressively through various stages, from pre-cachexia to cachexia to refractory cachexia, early screening and staging is particularly important to prevent or delay the onset of cachexia.(10) Consistent with its biochemical and molecular mechanisms, cachexia involves the secretion of tumour-de…”
BackgroundBeckonert, O., Keun, H. C., Ebbels, T. M. D., Bundy, J., Holmes, E., Lindon, J. C., & Nicholson, J. K. (2007) · Nature Protocols · doi:10.1038/nprot.2007.376 · Cited by 2,109 · cited 1×
“To ensure robust and reproducible data, all the samples were prepared according to the Bruker protocol.(23) Briefly, the samples were thawed at 4°C for 2 h and left at room temperature for 1 h.”
MethodReversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 940
Self-citationTemel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Petruzzelli, M., & Wagner, E. F. (2016) · Genes & Development · doi:10.1101/gad.276733.115 · Cited by 340 · cited 2×
“These metabolic disorders not only potentially underlie the pathogenesis of weight loss but also result in multiple and severe consequences, ranging from impairment of immune function to poor outcome to chemotherapy, fatigue, muscle weakness, and markedly reduced quality of life.(12,16) Moreover, metabolic dysfunction…”
BackgroundNew insights into pancreatic cancer-induced paraneoplastic diabetes
Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.49 · Cited by 334
Nutritional screening and early treatment of malnutrition in cancer patients
Santarpia, L., Contaldo, F., & Pasanisi, F. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0022-x · Cited by 267
Leucine nutrition in animals and humans: mTOR signaling and beyond
Li, F., Yin, Y., Tan, B., Kong, X., & Wu, G. (2011) · Amino Acids · doi:10.1007/s00726-011-0983-2 · Cited by 249 · cited 1×
“Consistent evidence has shown that BCAAs are not only important energy substrates but also act as precursors that improve nitrogen retention and protein synthesis.(32) Research has also shown that nutritional leucine supplementation can stimulate muscle protein anabolism, inhibit catabolism, and modulate glucose homeo…”
BackgroundGarcia, J. M., Boccia, R. V., Graham, C. D., Yan, Y., Duus, E. M., Allen, S., & Friend, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71154-4 · Cited by 218
von Haehling, S., Morley, J. E., Coats, A. J. S., & Anker, S. D. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12089 · Cited by 199 · cited 2×
“The authors certify that they comply with the ethical guidelines for authorship and publishing of the Journal of Cachexia, Sarcopenia and Muscle.40”
MethodThe role of insulin resistance in the development of muscle wasting during cancer cachexia
Honors, M. A., & Kinzig, K. P. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0051-5 · Cited by 167
Cancer Cachexia and Fat–Muscle Physiology
Fearon, K. C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmcibr1106880 · Cited by 156 · cited 2×
“It is associated with a reduced quality of life, reduced therapy response, and reduced treatment tolerance.(2,6) Recent clinical”
BackgroundWhy cachexia kills: examining the causality of poor outcomes in wasting conditions
Kalantar-Zadeh, K., Rhee, C., Sim, J. J., Stenvinkel, P., Anker, S. D., & Kovesdy, C. P. (2013) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-013-0111-0 · Cited by 149 · cited 1×
“and contributes to approximately 30% of cancer mortality.(5) It is associated with a reduced quality of life, reduced therapy response, and reduced treatment tolerance.”
Backgroundvan Norren, K., Kegler, D., Argilés, J. M., Luiking, Y., Gorselink, M., Laviano, A., Arts, K., Faber, J., Jansen, H., van der Beek, E. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604905 · Cited by 118
Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
Scheede‐Bergdahl, C., Watt, H. L., Trutschnigg, B., Kilgour, R. D., Haggarty, A., Lucar, E., & Vigano, A. A. L. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.07.010 · Cited by 115
Cancer‐ and endotoxin‐induced cachexia require intact glucocorticoid signaling in skeletal muscle
Braun, T. P., Grossberg, A. J., Krasnow, S. M., Levasseur, P. R., Szumowski, M., Zhu, X. X., Maxson, J. E., Knoll, J. G., Barnes, A. P., & Marks, D. L. (2013) · The FASEB Journal · doi:10.1096/fj.13-230375 · Cited by 103
Drescher, C., Konishi, M., Ebner, N., & Springer, J. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12082 · Cited by 94 · cited 2×
“This diagnostic criterion lags behind disease progression and has limited utility for the early diagnosis of cancer cachexia.(4) The emergence of metabolomics has immense potential for the early diagnosis and understanding of the pathogenesis of cancer cachexia.”
BackgroundGangi, I. M. D., Mazza, T., Fontana, A., Copetti, M., Fusilli, C., Ippolito, A. M., Mattivi, F., Latiano, A., Andriulli, A., Vrhovšek, U., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6808 · Cited by 93 · cited 1×
“Random forest analysis was executed to estimate the importance of each metabolite in the training dataset.(19)”
MethodSafety and Efficacy Evaluation of Carnosine, an Endogenous Neuroprotective Agent for Ischemic Stroke
Bae, O.-N., Serfozo, K., Baek, S.-H., Lee, K. Y., Dorrance, A., Rumbeiha, W., Fitzgerald, S. D., Farooq, M. U., Naravelta, B., Bhatt, A., et al. (2013) · Stroke · doi:10.1161/strokeaha.112.673954 · Cited by 91 · cited 1×
“Previous studies showed that carnosine supplementation can regulate brain function in some patients and elevate plasma corticosterone concentrations via the hypothalamicpituitary-adrenal axis.(29) Recent research has demonstrated that carnosine has the potential to suppress the multiple biochemical changes of protein…”
BackgroundThe correspondence problem for metabonomics datasets
Åberg, K. M., Alm, E., & Torgrip, R. J. O. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-2628-9 · Cited by 74 · cited 1×
“697, indicating reliable differentiation between the groups.(27)”
Girón, M. D., Vílchez, J. D., Salto, R., Manzano, M., Sevillano, N., Campos, N., Argilés, J. M. A., Rueda, R., & López-Pedrosa, J. M. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12032 · Cited by 73
Yang, Q., Huo, Y., Han, Y., Lili, W., Li, J., Huang, J., Jin, L., Peng-Guo, C., Gan, R., & Guo, C. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0324 · Cited by 62 · cited 1×
“It is associated with a reduced quality of life, reduced therapy response, and reduced treatment tolerance.(2,6) Recent clinical”
BackgroundSelf-citationNovel therapeutic options for cachexia and sarcopenia
Molfino, A., Amabile, M. I., Rossi Fanelli, F., & Muscaritoli, M. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1208168 · Cited by 54 · cited 1×
“Cachexia is thought to be the main cause of death in cancer patients, and its morbidity and mortality are high without effective treatment.(3,4) This condition occurs in nearly 80% of patients with advanced cancer OR IG INAL ART ICLE”
BackgroundDrescher, C., Konishi, M., Ebner, N., & Springer, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.033 · Cited by 53
Metabolomic analysis of cancer cachexia reveals distinct lipid and glucose alterations
O’Connell, T. M., Ardeshirpour, F., Asher, S. A., Winnike, J. H., Yin, X., George, J. R., Guttridge, D. C., He, W., Wysong, A. S., Willis, M. S., et al. (2008) · Metabolomics · doi:10.1007/s11306-008-0113-7 · Cited by 51 · cited 2×
“In the metabolic profile, decreased levels of glucose and elevated levels of lactate were observed in the cachexia patients’ sera, consistent with previous reports.(17,18) Enhanced glucose metabolism in cancer has been associated with glycolysis, leading to greater pyruvate and lactate formation via non-oxidative path…”
BackgroundResultArner, P., Henjes, F., Schwenk, J. M., Darmanis, S., Dahlman, I. A., Iresjö, B., Naredi, P. L. J., Agustsson, T., Lundholm, K., Nilsson, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123566 · Cited by 46 · cited 1×
“Low carnosine dipeptidase-1 levels have also been associated with poor cancer prognosis, including weight loss, malnutrition, lipid breakdown, low circulating albumin, IGF1 levels, and poor quality of life in gastrointestinal cancer.(31) These results, together with other recently published data, indicate that carnosi…”
ResultCarnosine and taurine contents of type I, IIA and IIB fibres in the middle gluteal muscle
DUNNETT, M., & HARRIS, R. C. (1995) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1995.tb04922.x · Cited by 41 · cited 1×
“Carnosine is a dipeptide of histidine and alanine that is present at high concentrations in skeletal muscle and brain tissue.(28) Previous studies showed that carnosine supplementation can regulate brain function in some patients and elevate plasma corticosterone concentrations via the hypothalamicpituitary-adrenal ax…”
BackgroundCaperuto, É. C., dos Santos, R. V. T., Colquhoun, A., Seelaender, M. C. L., & Rosa, L. F. B. P. C. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.05.007 · Cited by 32
Cancer Cachexia: From Molecular Mechanisms to Patient's Care
Lucia, S., Esposito, M., Fanelli, F. R., & Muscaritoli, M. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v17.i3.90 · Cited by 32 · cited 1×
“Cancer cachexia is characterized by weight loss, adipose tissue wasting, muscle atrophy, and loss of appetite.(11) A clinical diagnosis of cachexia requires patient weight-loss history and may be severely underestimated.”
BackgroundLeucine-stimulated mTOR signaling is partly attenuated in skeletal muscle of chronically uremic rats
Chen, Y., Sood, S., McIntire, K. L., Roth, R. A., & Rabkin, R. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00068.2011 · Cited by 31 · cited 1×
“Moreover, BCAAs are primarily catabolized in skeletal muscle, and they have been proposed for the treatment of catabolic disease states involving skeletal muscle wasting.(35,36) Despite their structural similarities, the branched-chain amino acids belong to different metabolic pathways, with leucine going solely to fa…”
BackgroundDisorders of the Urea Cycle and Related Enzymes
Wijburg, F. A., & Nassogne, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_20 · Cited by 27
Cancer cachexia’s metabolic signature in a murine model confirms a distinct entity
Der‐Torossian, H., Asher, S. A., Winnike, J. H., Wysong, A. S., Yin, X., Willis, M. S., O’Connell, T. M., & Couch, M. E. (2012) · Metabolomics · doi:10.1007/s11306-012-0485-6 · Cited by 26
Adipose tissue inflammation and cancer cachexia: the role of steroid hormones
Seelaender, M. C. L., & Júnior, M. L. B. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0040 · Cited by 26 · cited 1×
“These metabolic disorders not only potentially underlie the pathogenesis of weight loss but also result in multiple and severe consequences, ranging from impairment of immune function to poor outcome to chemotherapy, fatigue, muscle weakness, and markedly reduced quality of life.(12,16) Moreover, metabolic dysfunction…”
BackgroundSerum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice
Quanjun, Y., Genjin, Y., Lili, W., Li, B., Jin, L., Yu, Q., Li, Y., Yonglong, H., Guo, C., & Junping, Z. (2013) · Molecular BioSystems · doi:10.1039/c3mb70134d · Cited by 21
Self-citationBiomarkers for cardiac cachexia: Reality or utopia
Martins, T., Vitorino, R. M. P., Amado, F. M. L., Duarte, J. A., & Ferreira, R. M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.022 · Cited by 17 · cited 1×
“Currently, cachexia is diagnosed based on objective measures of clinical symptoms, and its diagnosis depends on a history of weight loss.(39) This diagnostic criterion lags behind disease progression and has limited utility for the early diagnosis of cancer cachexia.”
BackgroundQuanJun, Y., GenJin, Y., Lili, W., Huo, Y., YongLong, H., Jin, L., Li, J., JinLu, H., & Guo, C. (2015) · RSC Advances · doi:10.1039/c5ra19004e · Cited by 17 · cited 2×
“It should be noted that our previous study revealed changes in 13 metabolites from the intact muscle gastrocnemius and 43 metabolites from the serum in our murine dynamic cancer cachexia model.(20) The common changes in metabolites between murine and human samples included 2-oxoglutarate, 3-hydroxybutyrate, 3-methylhi…”
BackgroundResultSelf-citationMosnaim, A. D., Hudzik, T. J., & Wolf, M. E. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000337 · Cited by 6 · cited 1×
“It is produced endogenously by monoamine oxidase as the metabolite of 2-phenylethylamine, which may modulate central adrenergic functions.(37) Previous studies postulated that urine phenyl acetate may be a biomarker for depression.”
Background
Cited by
Yang, Y., Li, S., Wang, Y., Zhao, Y., & Li, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01168-8 · Cited by 294
Argilés, J. M., López-Soriano, F. J., Stemmler, B., & Busquets, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00734-5 · Cited by 246
Cancer metabolomic markers in urine: evidence, techniques and recommendations
Dinges, S. S., Hohm, A., Vandergrift, L. A., Nowak, J., Habbel, P., Kaltashov, I. A., & Cheng, L. L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0185-3 · Cited by 161
Arneson‐Wissink, P. C., Hogan, K. A., Ducharme, A. M., Samani, A., Jatoi, A., & Doles, J. D. (2020) · JCSM Rapid Communications · doi:10.1002/rco2.14 · Cited by 21
Metadata
- Authors
- Yang, Q., Zhao, J., Hao, J., Li, B., Huo, Y., Han, Y., Wan, L., Li, J., Huang, J., Lu, J., Yang, G., & Guo, C.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2017-11-19
- Volume
- 9
- Issue
- 1
- Pages
- 71-85
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2769276186
- Cited by
- 170
- References
- 37
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.